Conversational chatbots were the first chapter of AI. Today is the beginning of the second. We are excited to introduce Copilot Tasks — AI that doesn’t just talk to you, but works for you. This is a ...

Perplexity has introduced “Computer,” a new tool that allows users to assign tasks and see them carried out by a system that coordinates multiple agents running various models.

The software engineer is famous for his online stunts. Now he’s joining the company behind ChatGPT to work on new ways for ...

“In one year, President Trump has turned our country around from the brink of disaster, and he will rightly declare the state of our union is strong, prosperous and respected,” Karoline Leavitt, the ...

Replimune’s RP1+nivolumab melanoma BLA faces an FDA decision by Apr 10, 2026. The current cash runway extends to Q1'27. See more on REPL stock here.

Former Manchester United midfielder Owen Hargreaves has explained the tactical change implemented by caretaker manager ...

Shares of Replimune Group, Inc. (REPL) have gained 0.7% over the past four weeks to close the last trading session at $7.76, but there could still be a solid upside left in the stock if short-term ...

The coming months are set to define Replimune's trajectory. The FDA's decision on RP1 in April 2026 will establish the immediate commercial path, while the RP2 data expected later that same year will ...

byPhotosynthesis Technology: It's not just for plants! @photosynthesis Cultivating life through Photosynthesis, harnessing sunlight to nourish ecosystems and fuel a sustainable future.